FDA to Ban Inhalers Using CFCs After 2008
Posted on: Thursday, 31 March 2005, 12:00 CST
WASHINGTON - Inhalers using chlorofluorocarbons to dispense the drug albuterol will be banned at the end of 2008, the Food and Drug Administration said Thursday.
Chlorofluorocarbons, once widely used as aerosol propellants in a variety of products, have been removed from use because they can damage the Earth's protective ozone layer.
Their use with albuterol, which helps prevent wheezing, shortness of breath and troubled breathing caused by asthma, chronic bronchitis and emphysema, had been exempted from the ban.
The FDA said Thursday, however, that by Dec. 31, 2008, there will be sufficient supplies of albuterol inhalers using environmentally friendly propellants. So, as of that date, inhalers using CFC can no longer be produced, marketed or sold in the United States.
---
On the Net:
Food and Drug Administration: http://www.fda.gov
Source: Associated Press/AP Online
Related Articles
- Demographic Trends Creating Opportunities for Inhaled Drug Delivery
- Teva's Albuterol Inhaler Wins New Pediatric Indication
- Heart Problems Blamed On Inhaler Drugs
- Teva's ProAir(R) HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication
- Syndicated Cartoon Rex Morgan, M.D. Partners With AANMA to Focus on Asthma Awareness and Albuterol Inhaler Transition
- Akorn and Cipla to Develop Inhalation Drug Product
- Alexza Inhaled Drug Effective in Study
- American Lung Association and Teva Partner to Educate Asthma Community About the Transition From CFC to HFA Albuterol Inhalers
- FDA Warns 3 Compounders on Inhaled Drugs
- Apria Healthcare Comments On Office Of Inspector General (OIG) Report On Services Provided By Inhalation Drug Suppliers
 |
 |
User Comments (0)
RSS Feeds